| Year |
Citation |
Score |
| 2012 |
Ramachandran S, Temple B, Alexandrova AN, Chaney SG, Dokholyan NV. Recognition of platinum-DNA adducts by HMGB1a. Biochemistry. 51: 7608-17. PMID 22950413 DOI: 10.1021/Bi3008577 |
0.489 |
|
| 2012 |
King CL, Ramachandran S, Chaney SG, Collins L, Swenberg JA, DeKrafft KE, Lin W, Cicurel L, Barbier M. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells. Cancer Chemotherapy and Pharmacology. 69: 665-77. PMID 21968950 DOI: 10.1007/S00280-011-1744-3 |
0.355 |
|
| 2011 |
Bhattacharyya D, Ramachandran S, Sharma S, Pathmasiri W, King CL, Baskerville-Abraham I, Boysen G, Swenberg JA, Campbell SL, Dokholyan NV, Chaney SG. Flanking bases influence the nature of DNA distortion by platinum 1,2-intrastrand (GG) cross-links. Plos One. 6: e23582. PMID 21853154 DOI: 10.1371/Journal.Pone.0023582 |
0.502 |
|
| 2010 |
King CL, Ramachandran S, Chaney SG, Collins L, Swenberg JA, deKrafft KE, Lin W, Cicurel L, Barbier M. Abstract 3504: Debio 0507 primarily forms diaminocyclohexane-d(GpG) and -d(ApG) DNA adducts in HCT116 cells Cancer Research. 70: 3504-3504. DOI: 10.1158/1538-7445.Am10-3504 |
0.459 |
|
| 2009 |
Baskerville-Abraham IM, Boysen G, Troutman JM, Mutlu E, Collins L, Dekrafft KE, Lin W, King C, Chaney SG, Swenberg JA. Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts. Chemical Research in Toxicology. 22: 905-12. PMID 19323581 DOI: 10.1021/Tx800481J |
0.374 |
|
| 2009 |
Ramachandran S, Temple BR, Chaney SG, Dokholyan NV. Structural basis for the sequence-dependent effects of platinum-DNA adducts. Nucleic Acids Research. 37: 2434-48. PMID 19255091 DOI: 10.1093/Nar/Gkp029 |
0.439 |
|
| 2009 |
Shachar S, Ziv O, Avkin S, Adar S, Wittschieben J, Reissner T, Chaney S, Friedberg EC, Wang Z, Carell T, Geacintov N, Livneh Z. Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. The Embo Journal. 28: 383-93. PMID 19153606 DOI: 10.1038/Emboj.2008.281 |
0.422 |
|
| 2009 |
Shachar S, Ziv O, Avkin S, Adar S, Wittschieben J, Reißner T, Chaney S, Friedberg EC, Wang Z, Carell T, Geacintov N, Livneh Z. Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals The Embo Journal. 28: 992-992. DOI: 10.1038/Emboj.2009.72 |
0.376 |
|
| 2007 |
Sharma S, Gong P, Temple B, Bhattacharyya D, Dokholyan NV, Chaney SG. Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics. Journal of Molecular Biology. 373: 1123-40. PMID 17900616 DOI: 10.1016/J.Jmb.2007.07.079 |
0.484 |
|
| 2007 |
Wu Y, Bhattacharyya D, King CL, Baskerville-Abraham I, Huh SH, Boysen G, Swenberg JA, Temple B, Campbell SL, Chaney SG. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link. Biochemistry. 46: 6477-87. PMID 17497831 DOI: 10.1021/Bi062291F |
0.496 |
|
| 2006 |
Avkin S, Sevilya Z, Toube L, Geacintov N, Chaney SG, Oren M, Livneh Z. p53 and p21 regulate error-prone DNA repair to yield a lower mutation load. Molecular Cell. 22: 407-13. PMID 16678112 DOI: 10.1016/J.Molcel.2006.03.022 |
0.436 |
|
| 2005 |
Chaney SG, Campbell SL, Bassett E, Wu Y. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts. Critical Reviews in Oncology/Hematology. 53: 3-11. PMID 15607931 DOI: 10.1016/J.Critrevonc.2004.08.008 |
0.714 |
|
| 2004 |
Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M. Protein interactions with platinum-DNA adducts: from structure to function. Journal of Inorganic Biochemistry. 98: 1551-9. PMID 15458816 DOI: 10.1016/J.Jinorgbio.2004.04.024 |
0.7 |
|
| 2004 |
Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, Cordeiro-Stone M. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts. Cancer Research. 64: 6469-75. PMID 15374956 DOI: 10.1158/0008-5472.Can-04-1328 |
0.686 |
|
| 2004 |
Wu Y, Pradhan P, Havener J, Boysen G, Swenberg JA, Campbell SL, Chaney SG. NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex. Journal of Molecular Biology. 341: 1251-69. PMID 15321720 DOI: 10.1016/J.Jmb.2004.06.066 |
0.349 |
|
| 2003 |
Bassett E, Vaisman A, Havener JM, Masutani C, Hanaoka F, Chaney SG. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro. Biochemistry. 42: 14197-206. PMID 14640687 DOI: 10.1021/Bi035359P |
0.677 |
|
| 2003 |
Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu. Biochemistry. 42: 1777-88. PMID 12578393 DOI: 10.1021/Bi0270079 |
0.691 |
|
| 2002 |
Bassett E, Vaisman A, Tropea KA, McCall CM, Masutani C, Hanaoka F, Chaney SG. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta. Dna Repair. 1: 1003-16. PMID 12531010 DOI: 10.1016/S1568-7864(02)00150-7 |
0.668 |
|
| 2001 |
Vaisman A, Warren MW, Chaney SG. The Effect of DNA Structure on the Catalytic Efficiency and Fidelity of Human DNA Polymerase β on Templates with Platinum-DNA Adducts Journal of Biological Chemistry. 276: 18999-19005. PMID 11259423 DOI: 10.1074/Jbc.M007805200 |
0.514 |
|
| 2000 |
Woynarowski JM, Faivre S, Herzig MCS, Arnett B, Chapman WG, Trevino AV, Raymond E, Chaney SG, Vaisman A, Varchenko M, Juniewicz PE. Oxaliplatin-induced damage of cellular DNA Molecular Pharmacology. 58: 920-927. PMID 11040038 DOI: 10.1124/Mol.58.5.920 |
0.493 |
|
| 2000 |
Vaisman A, Chaney SG. The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase β Journal of Biological Chemistry. 275: 13017-13025. PMID 10777605 DOI: 10.1074/Jbc.275.17.13017 |
0.491 |
|
| 2000 |
Vaisman A, Masutani C, Hanaoka F, Chaney SG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η Biochemistry. 39: 4575-4580. PMID 10769112 DOI: 10.1021/Bi000130K |
0.55 |
|
| 1999 |
Chaney SG, Vaisman A. Specificity of platinum-DNA adduct repair Journal of Inorganic Biochemistry. 77: 71-81. PMID 10626357 DOI: 10.1016/S0162-0134(99)00149-X |
0.552 |
|
| 1999 |
Reardon JT, Vaisman A, Chaney SG, Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bis- acetoammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts Cancer Research. 59: 3968-3971. PMID 10463593 |
0.417 |
|
| 1999 |
Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, Chaney SG. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. Biochemistry. 38: 11026-39. PMID 10460158 DOI: 10.1021/Bi9909187 |
0.553 |
|
| 1999 |
Luo FR, Wyrick SD, Chaney SG. Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model Cancer Chemotherapy and Pharmacology. 44: 29-38. PMID 10367746 DOI: 10.1007/S002800050941 |
0.362 |
|
| 1999 |
Luo FR, Wyrick SD, Chaney SG. Pharmacokinetics biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats Cancer Chemotherapy and Pharmacology. 44: 19-28. PMID 10367745 DOI: 10.1007/S002800050940 |
0.355 |
|
| 1999 |
Luo FR, Yen TY, Wyrick SD, Chaney SG. High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin. Journal of Chromatography. B, Biomedical Sciences and Applications. 724: 345-56. PMID 10219677 DOI: 10.1016/S0378-4347(98)00565-9 |
0.339 |
|
| 1999 |
Luo FR, Wyrick SD, Chaney SG. Biotransformations of oxaliplatin in rat blood in vitro Journal of Biochemical and Molecular Toxicology. 13: 159-169. PMID 10098901 DOI: 10.1002/(Sici)1099-0461(1999)13:3/4<159::Aid-Jbt6>3.0.Co;2-C |
0.346 |
|
| 1999 |
Ding H, Goldberg MM, Raymer JH, Holmes J, Stanko J, Chaney SG. Determination of platinum in rat dorsal root ganglion using ICP-MS Biological Trace Element Research. 67: 1-11. PMID 10065593 DOI: 10.1007/Bf02784270 |
0.313 |
|
| 1998 |
Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: A review of preclinical and clinical studies Annals of Oncology. 9: 1053-1071. PMID 9834817 DOI: 10.1023/A:1008213732429 |
0.321 |
|
| 1998 |
Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts Cancer Research. 58: 3579-3585. PMID 9721864 |
0.371 |
|
| 1997 |
Vaisman A, Varchenko M, Said I, Chaney SG. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity Cytometry. 27: 54-64. PMID 9000585 DOI: 10.1002/(Sici)1097-0320(19970101)27:1<54::Aid-Cyto7>3.0.Co;2-L |
0.397 |
|
| 1997 |
Delmastro DA, Li J, Vaisman A, Solle M, Chaney SG. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines Cancer Chemotherapy and Pharmacology. 39: 245-253. PMID 8996528 DOI: 10.1007/S002800050568 |
0.475 |
|
| 1996 |
Petersen LN, Mamenta EL, Stevnsner T, Chaney SG, Bohr VA. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity Carcinogenesis. 17: 2597-2602. PMID 9006094 DOI: 10.1093/Carcin/17.12.2597 |
0.372 |
|
| 1996 |
Chaney SG, Sancar A. DNA repair: Enzymatic mechanisms and relevance to drug response Journal of the National Cancer Institute. 88: 1346-1360. PMID 8827012 DOI: 10.1093/Jnci/88.19.1346 |
0.488 |
|
| 1996 |
Vaisman A, Keeney S, Nichols AF, Linn S, Chaney SG. Cisplatin-induced alterations in the expression of the mRNAs for UV-damage recognition protein. Oncology Research. 8: 7-12. PMID 8704286 |
0.318 |
|
| 1995 |
Vaisman A, Chaney SG. Induction of UV-damage recognition protein by cisplatin treatment Biochemistry®. 34: 105-114. PMID 7819185 DOI: 10.1021/Bi00001A013 |
0.477 |
|
| 1995 |
Thompson DC, Wyrick SD, Holbrook DJ, Chaney SG. HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721). Biochemical Pharmacology. 50: 1413-9. PMID 7503792 DOI: 10.1016/0006-2952(96)84545-X |
0.381 |
|
| 1995 |
Chaney SG. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand International Journal of Oncology. 6: 1291-1305. |
0.31 |
|
| 1994 |
Petros WP, Chaney SG, Smith DC, Fangmeier J, Sakata M, Brown TD, Trump DL. Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial Cancer Chemotherapy and Pharmacology. 33: 347-354. PMID 8281629 DOI: 10.1007/Bf00685911 |
0.307 |
|
| 1994 |
Shamkhani H, Anderson LM, Henderson CE, Moskal TJ, Runowicz CD, Dove LF, Jones AB, Chaney SG, Rice JM, Poirier MC. DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy. Reproductive Toxicology (Elmsford, N.Y.). 8: 207-16. PMID 8075509 DOI: 10.1016/0890-6238(94)90004-3 |
0.436 |
|
| 1994 |
Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Research. 54: 3500-5. PMID 8012973 |
0.37 |
|
| 1992 |
Nichols AF, Schmidt WJ, Chaney SG, Sancar A. Limitations of the in vitro repair synthesis assay for probing the role of DNA repair in platinum resistance Chemico-Biological Interactions. 81: 223-231. PMID 1540994 DOI: 10.1016/0009-2797(92)90079-Z |
0.441 |
|
| 1991 |
Carfagna PF, Poma A, Wyrick SD, Holbrook DJ, Chaney SG. Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexaneplatinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic doses Cancer Chemotherapy and Pharmacology. 27: 335-341. PMID 1998992 DOI: 10.1007/Bf00688854 |
0.325 |
|
| 1991 |
Thomas DC, Husain I, Chaney SG, Panigrahi GB, Walker IG. Sequence effect on incision by (A)BC excinuclease of 4NQO adducts and uv photoproducts Nucleic Acids Research. 19: 365-370. PMID 1901645 DOI: 10.1093/Nar/19.2.365 |
0.447 |
|
| 1991 |
Gibbons GR, Page JD, Chaney SG. Treatment of DNA with ammonium bicarbonate or thiourea can lead to underestimation of platinum-DNA monoadducts Cancer Chemotherapy and Pharmacology. 29: 112-116. PMID 1760852 DOI: 10.1007/Bf00687319 |
0.486 |
|
| 1991 |
Gibbons GR, Kaufmann WK, Chaney SG. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in l1210 cells Carcinogenesis. 12: 2253-2257. PMID 1747924 DOI: 10.1093/Carcin/12.12.2253 |
0.46 |
|
| 1991 |
Carfagna PF, Wyrick SD, Holbrook DJ, Chaney SG. Effects of diethyldithiocarbamate (ddtc) on the plasma biotransformations of tetrachloro(d,i‐trans)‐1,2‐diaminocyclohexaneplatinum(iv) (tetraplatin) in fischer 344 rats Journal of Biochemical Toxicology. 6: 71-80. PMID 1652641 DOI: 10.1002/Jbt.2570060110 |
0.33 |
|
| 1990 |
Page JD, Husain I, Sancar A, Chaney SG. Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality Biochemistry. 29: 1016-1024. PMID 2340275 DOI: 10.1021/Bi00456A026 |
0.381 |
|
| 1990 |
Oswald CB, Chaney SG, Hall IH. Inhibition of DNA synthesis in P388 lymphocytic leukemia cells of BDF1 mice by cis-Diamminedichloroplatinum(II) and its derivatives Journal of Pharmaceutical Sciences. 79: 875-880. PMID 2280354 DOI: 10.1002/Jps.2600791006 |
0.527 |
|
| 1990 |
Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG. Role of Carrier Ligand in Platinum Resistance in LI 210 Cells Cancer Research. 50: 6497-6501. PMID 2208108 |
0.328 |
|
| 1990 |
Oswald CB, Chaney SG, Hall IH. Inhibition of nucleic acid synthesis in P388 lymphocytic leukemia cells in culture by cis-platinum derivatives Biomedica Biochimica Acta. 49: 579-587. PMID 1704216 |
0.455 |
|
| 1990 |
Carfagna PF, Chaney SG, Chang J, Holbrook DJ. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the fischer 344 rat Toxicological Sciences. 14: 706-719. DOI: 10.1016/0272-0590(90)90296-V |
0.303 |
|
| 1990 |
Wyrick SD, Chaney SG. Synthesis of [195mPt]‐tetraplatin Journal of Labelled Compounds and Radiopharmaceuticals. 28: 753-756. DOI: 10.1002/Jlcr.2580280703 |
0.358 |
|
| 1988 |
Mauldin SK, Plescia M, Richard FA, Wyrick SD, Voyksner RD, Chaney SG. Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II)by physiologically important compounds in vitro Biochemical Pharmacology. 37: 3321-3333. PMID 3401260 DOI: 10.1016/0006-2952(88)90646-6 |
0.339 |
|
| 1988 |
Williams WL, Hall IH, Grippo AA, Oswald CB, Lee KH, Holbrook DJ, Chaney SG. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo. Journal of Pharmaceutical Sciences. 77: 178-84. PMID 2896234 DOI: 10.1002/Jps.2600770217 |
0.425 |
|
| 1988 |
Hall IH, Williams WL, Grippo AA, Lee KH, Holbrook DJ, Chaney SG. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones. Anticancer Research. 8: 33-42. PMID 2895992 |
0.38 |
|
| 1988 |
Wyrick SD, Chaney SG. Tritiated platinum antitumor agents containing the trans‐(d,1)‐1,2‐diaminocyclohexane carrier ligand Journal of Labelled Compounds and Radiopharmaceuticals. 25: 349-357. DOI: 10.1002/Jlcr.2580250402 |
0.332 |
|
| 1987 |
Hall IH, Grippo AA, Lee KH, Chaney SG, Holbrook DJ. Effect of Helenalin and Bis(helenalinyl)malonate on Nucleic Acid and Protein Synthesis in Human KB Carcinoma Cells Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 4: 509-514. PMID 2907784 DOI: 10.1023/A:1016435807362 |
0.474 |
|
| 1986 |
Mauldin SK, Richard FA, Plescia M, Wyrick SD, Sancar A, Chaney SG. High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand Analytical Biochemistry. 157: 129-143. PMID 3766956 DOI: 10.1016/0003-2697(86)90206-X |
0.301 |
|
| 1985 |
Husain I, Chaney SG, Sancar A. Repair of cis-platinum-DNA adducts by ABC excinuclease in vivo and in vitro Journal of Bacteriology. 163: 817-823. PMID 3897194 DOI: 10.1128/Jb.163.3.817-823.1985 |
0.495 |
|
| 1985 |
Hall IH, Williams WL, Chaney SG, Gilbert CJ, Holbrook DJ, Muraoka O, Kiyokawa H, Lee KH. Antitumor agents 68: effects of a series of helenalin derivatives on P-388 lymphocytic leukemia nucleic acid and protein synthesis. Journal of Pharmaceutical Sciences. 74: 250-4. PMID 2861271 DOI: 10.1002/Jps.2600740306 |
0.485 |
|
| 1985 |
Husain I, Chaney SG, Sancar A. Repair of cis-platinum-DNA adducts by ABC excinuclease in vivo and in vitro. Journal of Bacteriology. 163: 817-823. DOI: 10.1128/jb.163.3.817-823.1985 |
0.362 |
|
| 1984 |
Willingham W, Tobias Considine R, Chaney SG, Lee KH, Hall IH. Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system Biochemical Pharmacology. 33: 330-333. PMID 6704156 DOI: 10.1016/0006-2952(84)90494-5 |
0.327 |
|
| 1984 |
Williams WL, Chaney SG, Hall IH, Lee KH. Indirect inactivation of rabbit reticulocyte initiation factor eIF-2 by helenalin and bis(helenalinyl) malonate. Biochemistry. 23: 5637-44. PMID 6095903 DOI: 10.1021/Bi00318A039 |
0.337 |
|
| 1984 |
Chaney SG, Williams WL, Willingham W, Considine RT, Hall IH, Lee KH. Inhibition of protein synthesis initiation factors by naturally occurring sulfhydryl reactive reagents. Current Topics in Cellular Regulation. 24: 251-60. PMID 6094109 DOI: 10.1016/B978-0-12-152824-9.50030-7 |
0.354 |
|
| 1983 |
Hall IH, Liou YF, Lee KH, Chaney SG, Willingham W. Antitumor agents LIX: Effects of quassinoids on protein synthesis of a number of murine tumors and normal cells Journal of Pharmaceutical Sciences. 72: 626-630. PMID 6875823 DOI: 10.1002/Jps.2600720612 |
0.34 |
|
| 1983 |
Williams WL, Chaney SG, Willingham W, Considine RT, Hall IH, Lee KH. Selective inactivation of rabbit reticulocyte initiation factor eIF-3 by helenalin. Biochimica Et Biophysica Acta. 740: 152-62. PMID 6860667 DOI: 10.1016/0167-4781(83)90072-6 |
0.32 |
|
| 1983 |
CONSIDINE RT, WILLINGHAM W, CHANEY SG, WYRICK S, HALL IH, LEE K‐. Structure‐Activity Relationships for Binding and Inactivation of Rabbit Reticulocyte Ribosomes by Quassinoid Antineoplastic Agents European Journal of Biochemistry. 132: 157-163. PMID 6840079 DOI: 10.1111/J.1432-1033.1983.Tb07341.X |
0.304 |
|
| 1983 |
Liou YF, Hall IH, Lee KH, Williams WL, Chaney SG. Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells. Biochimica Et Biophysica Acta. 739: 190-6. PMID 6824673 DOI: 10.1016/0167-4781(83)90029-5 |
0.35 |
|
| 1982 |
Liou YF, Hall IH, Okano M, Lee KH, Chaney SG. Antitumor agents XLVIII: Structure—activity relationships of quassinoids as in vitro protein synthesis inhibitors of P‐388 lymphocytic leukemia tumor cell metabolism Journal of Pharmaceutical Sciences. 71: 430-435. PMID 7086652 DOI: 10.1002/Jps.2600710414 |
0.373 |
|
| 1982 |
Hall IH, Liou YF, Lee KH, Okano M, Chaney SG. Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P‐388 lymphocytic leukemia cell metabolism Journal of Pharmaceutical Sciences. 71: 257-262. PMID 6278124 DOI: 10.1002/Jps.2600710229 |
0.428 |
|
| 1981 |
Willingham W, Stafford EA, Reynolds SH, Chaney SG, Lee KH, Okano M, Hall IH. Mechanism of eukaryotic protein synthesis inhibition by brusatol. Biochimica Et Biophysica Acta. 654: 169-74. PMID 7284376 DOI: 10.1016/0005-2787(81)90168-4 |
0.349 |
|
| 1978 |
Harris JS, van Tassel E, Chaney SG. A mutation in Escherichia coli that mimics diauxie lag Biochemical and Biophysical Research Communications. 82: 982-989. PMID 358971 DOI: 10.1016/0006-291X(78)90880-X |
0.305 |
|
| 1977 |
Chaney SG, Jackson JM, Harris JS. A new mutation affecting ribosomal RNA synthesis in Escherichia coli Biochemistry. 16: 3603-3607. PMID 407931 DOI: 10.1021/Bi00635A016 |
0.342 |
|
| 1975 |
Chaney SG, Schlessinger D. Escherichia coli mutants deficient in RNA accumulation at high temperature Bba Section Nucleic Acids and Protein Synthesis. 378: 80-91. PMID 1091293 DOI: 10.1016/0005-2787(75)90139-2 |
0.317 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1998 |
Holmes J, Stanko J, Varchenko M, Hong H, Madden VJ, Bagnell CR, Wyrick SD, Chaney SG. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a wistar rat model Toxicological Sciences. 46: 342-351. PMID 10048138 DOI: 10.1006/Toxs.1998.2558 |
0.299 |
|
| 1990 |
Rosenblum MG, Murray JL, Stuckey S, Newman RA, Chaney S, Khokhar AR. Modification of methyliminodiacetato-trans-R,R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody. Cancer Chemotherapy and Pharmacology. 25: 405-10. PMID 2311167 DOI: 10.1007/Bf00686050 |
0.299 |
|
| 1987 |
Page JD, Chaney SG, Hall IH, Lee KH, Holbrook DJ. Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones Bba - General Subjects. 926: 186-194. PMID 2889474 DOI: 10.1016/0304-4165(87)90236-4 |
0.295 |
|
| 1993 |
Schmidt W, Chaney SG. Role of Carrier Ligand in Platinum Resistance of Human Carcinoma Cell Lines Cancer Research. 53: 799-805. PMID 8428361 |
0.295 |
|
| 1998 |
Raymond E, Faivre S, Woynarowski JM, Chaney SG. Oxaliplatin: Mechanism of action and antineoplastic activity Seminars in Oncology. 25: 4-12. PMID 9609103 |
0.294 |
|
| 1978 |
Harris JS, Chaney SG. Guanine nucleotide metabolism in a mutant strain of Escherichia coli with a temperature sensitive lesion in rRNA synthesis Bba Section Nucleic Acids and Protein Synthesis. 521: 634-640. PMID 367439 DOI: 10.1016/0005-2787(78)90304-0 |
0.289 |
|
| 1989 |
Chapman DE, Holbrook DJ, Chaney SG, Hall IH, Lee KH. In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone. Biochemical Pharmacology. 38: 3913-23. PMID 2512929 DOI: 10.1016/0006-2952(89)90668-0 |
0.288 |
|
| 1990 |
Hall IH, Grippo AA, Holbrook DJ, Chang JJ, Yang LM, Chaney SG, Lee KH. Renal, hepatic, cardiac and thymic acute toxicity afforded by bis(helenalinyl)malonate in BDF1 mice Toxicology. 64: 205-216. PMID 2219141 DOI: 10.1016/0300-483X(90)90136-5 |
0.277 |
|
| 1998 |
Luo FR, Wyrick SD, Chaney SG. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells Oncology Research. 10: 595-603. PMID 10367941 |
0.277 |
|
| 1983 |
Reynolds SH, Chaney SG. Carbon source transport, nucleotide levels, and stable RNA synthesis in a mutant strain of Escherichia coli. Archives of Biochemistry and Biophysics. 221: 548-56. PMID 6188414 DOI: 10.1016/0003-9861(83)90174-1 |
0.276 |
|
| 2003 |
Raymond E, Faivre S, Chaney S, Woynarowski J, Cvitkovic E. Cellular and molecular pharmacology of oxaliplatin. Molecular Cancer Therapeutics. 1: 227-35. PMID 12467217 |
0.274 |
|
| 1988 |
Mauldin SK, Gibbons G, Wyrick SD, Chaney SG. Intracellular Biotransformation of Platinum Compounds with the 1,2-Diaminocyclohexane Carrier Ligand in the L1210 Cell Line Cancer Research. 48: 5136-5144. PMID 3409241 |
0.272 |
|
| 1986 |
Mauldin SK, Husain I, Sancar A, Chaney SG. Effects of the Bidentate Malonate Ligand on the Utilization and Cytotoxicity of Platinum Compounds in the L1210 Cell Line Cancer Research. 46: 2876-2882. PMID 3698013 |
0.262 |
|
| 1991 |
Chapman DE, Holbrook DJ, Chaney SG, Hall IH, Lee KH. In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450. Biochemical Pharmacology. 41: 229-35. PMID 1989634 DOI: 10.1016/0006-2952(91)90481-J |
0.257 |
|
| 1988 |
Chapman DE, Roberts GB, Reynolds DJ, Grippo AA, Holbrook DJ, Hall IH, Chaney SG, Chang J, Lee KH. Acute toxicity of helenalin in BDF1 mice. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 10: 302-12. PMID 3356317 DOI: 10.1093/Toxsci/10.2.302 |
0.256 |
|
| 1983 |
Reynolds SH, Brantley CK, Harris JS, Chaney SG. Guanosine 5'-diphosphate 3'-diphosphate levels, carbon source, and ribonucleic acid synthesis in a mutant strain of Escherichia coli. Biochemistry. 22: 1123-8. PMID 6188485 DOI: 10.1021/Bi00274A020 |
0.253 |
|
| 1989 |
Gibbons GR, Wyrick S, Chaney SG. Rapid Reduction of Tetrachloro(D,L-trans)l,2-diaminocyclohexaneplatinum(IV) (Tetraplatin) in RPMI 1640 Tissue Culture Medium Cancer Research. 49: 1402-1407. PMID 2924297 |
0.236 |
|
| 1995 |
Thompson DC, Wyrick SD, Holbrook DJ, Chaney SG. Effects of anesthetics on qrmaplatin biotransformations in the fischer 344 rat Cancer Investigation. 13: 555-557. PMID 7552825 DOI: 10.3109/07357909509024922 |
0.204 |
|
| 1990 |
Chaney SG, Till GK, Wyrick S. In Vitro Biotransformations of Tetrachloro(d,1-trans)-1,2-diaminocyclohexaneplatinum(IV) (Tetraplatin) in Rat Plasma Cancer Research. 50: 4539-4545. PMID 2196115 |
0.194 |
|
| 2002 |
Shord SS, Bernard SA, Lindley C, Blodgett A, Mehta V, Churchel MA, Poole M, Pescatore SL, Luo FR, Chaney SG. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity. Anticancer Research. 22: 2301-9. PMID 12174918 |
0.188 |
|
| 1983 |
Williams DE, Jackson JM, Chaney SG. Characterization of RNA synthesis in an Escherichia coli mutant with a temperature-sensitive lesion in stable RNA synthesis Journal of Bacteriology. 153: 616-626. PMID 6185464 |
0.186 |
|
| 1981 |
Willingham W, Chaney SG. Mechanism of protein synthesis inhibition by brusatol and related quassinoids Federation Proceedings. 40: 1774. |
0.178 |
|
| 2002 |
Mani S, Graham MA, Bregman DB, Ivy P, Chaney SG. Oxaliplatin: a review of evolving concepts. Cancer Investigation. 20: 246-63. PMID 11901545 DOI: 10.1081/Cnv-120001152 |
0.174 |
|
| 1995 |
Thompson DC, Wyrick SD, Holbrook DJ, Chaney SG. Effect of the Chemoprotective Agent WR-2721 on Disposition and Biotransformations of Ormaplatin in the Fischer 344 Rat Bearing a Fibrosarcoma Cancer Research. 55: 2837-2846. PMID 7796411 |
0.17 |
|
| 1995 |
Thompson DC, Vaisman A, Sakata MK, Wyrick SD, Holbrook DJ, Chaney SG. Organ-specific biotransformation of ormaplatin in the Fischer 344 rat. Cancer Chemotherapy and Pharmacology. 36: 439-47. PMID 7634386 DOI: 10.1007/BF00686194 |
0.156 |
|
| 1987 |
Wyrick SD, Chaney SG. Re: Effects of bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line Cancer Research. 47: 4992. PMID 3621186 |
0.134 |
|
| 1989 |
Oswald CB, Wyrick SD, Chaney SG, Shrewsbury RO, Hall IH. Disposition of cisplatin derivatives -3H-cis-1,2-diaminocyclohexanedichloro-platinum (II) and 3H-cis-1,2-diaminocyclohexanemalonato-platinum (II) in BDF1 mice Research Communications in Chemical Pathology and Pharmacology. 64: 41-58. PMID 2749002 |
0.134 |
|
| 1984 |
Mauldin SK, Chaney SG. Characterization and quantitation of the intracellular metabolites of some second generation cis-platinum antitumor drugs Federation Proceedings. 43. |
0.13 |
|
| 2002 |
Hall MC, Bassett E, Nikolaishvili-Feinberg N, Chaney SG, Cordeiro-Stone M, Borchers CH. Identification of protein-protein interactions both in vitro and in vivo using photochemical crosslinking and mass spectrometry Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 249-250. |
0.111 |
|
| 1995 |
Sakata M, Chaney SG, Spriggs DR. Possible correlation between ormaplatin biotransformations and neurotoxicity Oncology Research. 7: 67-71. PMID 7579729 |
0.111 |
|
| 1972 |
Chaney SG, Boyer PD. Incorporation of water oxygens into intracellular nucleotides and RNA. II. Predominantly hydrolytic RNA turnover in Escherichia coli Journal of Molecular Biology. 64: 581-591. PMID 4553854 DOI: 10.1016/0022-2836(72)90084-8 |
0.097 |
|
| 1972 |
Duffy JJ, Chaney SG, Boyer PD. Incorporation of water oxygens into intracellular nucleotides and RNA. I. Predominantly non-hydrolytic RNA turnover in Bacillus subtilis Journal of Molecular Biology. 64: 565-579. PMID 4336697 DOI: 10.1016/0022-2836(72)90083-6 |
0.094 |
|
| 1972 |
Chaney SG, Duffy JJ, Boyer PD. Patterns of oxygen interchange between water, substrates, and phosphate compounds of Escherichia coli and Bacillus subtilis Journal of Biological Chemistry. 247: 2145-2150. PMID 4622742 |
0.08 |
|
| 1976 |
Jackson JM, Chaney SG. Escherichia coli mutants with altered ribosomal ribonucleic acid metabolism Journal of Bacteriology. 125: 1057-1073. PMID 767320 |
0.076 |
|
| 2002 |
Adams B, Fitch T, Chaney S, Gerlai R. Altered performance characteristics in cognitive tasks: comparison of the albino ICR and CD1 mouse strains. Behavioural Brain Research. 133: 351-61. PMID 12110469 DOI: 10.1016/S0166-4328(02)00020-7 |
0.074 |
|
| 2002 |
Fitch T, Adams B, Chaney S, Gerlai R. Force transducer-based movement detection in fear conditioning in mice: a comparative analysis. Hippocampus. 12: 4-17. PMID 11918287 DOI: 10.1002/Hipo.10009 |
0.064 |
|
| 1966 |
Chaney SG, Kare MR. Emesis in birds Journal of the American Veterinary Medical Association. 149: 938-943. PMID 22413208 |
0.045 |
|
| 1969 |
Chaney SG, Boyer PD. Lack of detection of intermediates in the path of phosphate oxygen to water in photophosphorylation Journal of Biological Chemistry. 244: 5773-5776. PMID 5350934 |
0.041 |
|
| 2016 |
Wyrick SD, Chaney SG. Letter to the Editor Cancer Research. 47: 4992. |
0.01 |
|
| Hide low-probability matches. |